• Ticker

DJIA 12,890.46 6.51 0.05%
NASDAQ 2,927.23 11.37 0.39%
S&P 500 1,351.95 1.99 0.15%
Maintenance Notification

Quotes and Portfolios will be down on Sunday February 12, 2012 from 2 AM to 4 AM while we perform maintenance on the site. We apologize for the inconvenience.

$10.00 $0.12 (1.21%)

Quote as of 4:00 PM EST on 02/09/12

Human Genome Sciences

NASDAQ:HGSI

HGSI vs. S&P 500
$10.00 $0.12 (1.21%)
Today's Open $9.96
Previous Close $9.88
Daily Range $9.60 - $10.27
52-Week Range $6.51 - $30.15
Market Cap $1.99B
P/E Ratio -4.89
Dividend (Yield) $0.00 (0.0%)
Volume 6,769,567
Average Daily Volume 8,230,462
Current FY EPS -$1.97

HGSI Information

Description
The drug development company with three products advancing into late-stage clinical development: Albuferon(r) for chronic hepatitis C, LymphoStat-B(r) for systemic lupus erythematosus, and ABthraxtm for anthrax disease.
Sector
Healthcare
Industry
Biotechnology

News & Commentary

HGSI's Top Competitors

HGSI

$10.00 (1.21%)

Current stock: HGSI
AMGN

$66.84 (-1.79%)

Current stock: AMGN
GILD

$53.73 (-1.00%)

Current stock: GILD
BIIB

$117.78 (-1.52%)

Current stock: BIIB